Exome Sequencing and the Management of Neurometabolic Disorders.

نویسندگان

  • Maja Tarailo-Graovac
  • Casper Shyr
  • Colin J Ross
  • Gabriella A Horvath
  • Ramona Salvarinova
  • Xin C Ye
  • Lin-Hua Zhang
  • Amit P Bhavsar
  • Jessica J Y Lee
  • Britt I Drögemöller
  • Mena Abdelsayed
  • Majid Alfadhel
  • Linlea Armstrong
  • Matthias R Baumgartner
  • Patricie Burda
  • Mary B Connolly
  • Jessie Cameron
  • Michelle Demos
  • Tammie Dewan
  • Janis Dionne
  • A Mark Evans
  • Jan M Friedman
  • Ian Garber
  • Suzanne Lewis
  • Jiqiang Ling
  • Rupasri Mandal
  • Andre Mattman
  • Margaret McKinnon
  • Aspasia Michoulas
  • Daniel Metzger
  • Oluseye A Ogunbayo
  • Bojana Rakic
  • Jacob Rozmus
  • Peter Ruben
  • Bryan Sayson
  • Saikat Santra
  • Kirk R Schultz
  • Kathryn Selby
  • Paul Shekel
  • Sandra Sirrs
  • Cristina Skrypnyk
  • Andrea Superti-Furga
  • Stuart E Turvey
  • Margot I Van Allen
  • David Wishart
  • Jiang Wu
  • John Wu
  • Dimitrios Zafeiriou
  • Leo Kluijtmans
  • Ron A Wevers
  • Patrice Eydoux
  • Anna M Lehman
  • Hilary Vallance
  • Sylvia Stockler-Ipsiroglu
  • Graham Sinclair
  • Wyeth W Wasserman
  • Clara D van Karnebeek
چکیده

BACKGROUND Whole-exome sequencing has transformed gene discovery and diagnosis in rare diseases. Translation into disease-modifying treatments is challenging, particularly for intellectual developmental disorder. However, the exception is inborn errors of metabolism, since many of these disorders are responsive to therapy that targets pathophysiological features at the molecular or cellular level. METHODS To uncover the genetic basis of potentially treatable inborn errors of metabolism, we combined deep clinical phenotyping (the comprehensive characterization of the discrete components of a patient's clinical and biochemical phenotype) with whole-exome sequencing analysis through a semiautomated bioinformatics pipeline in consecutively enrolled patients with intellectual developmental disorder and unexplained metabolic phenotypes. RESULTS We performed whole-exome sequencing on samples obtained from 47 probands. Of these patients, 6 were excluded, including 1 who withdrew from the study. The remaining 41 probands had been born to predominantly nonconsanguineous parents of European descent. In 37 probands, we identified variants in 2 genes newly implicated in disease, 9 candidate genes, 22 known genes with newly identified phenotypes, and 9 genes with expected phenotypes; in most of the genes, the variants were classified as either pathogenic or probably pathogenic. Complex phenotypes of patients in five families were explained by coexisting monogenic conditions. We obtained a diagnosis in 28 of 41 probands (68%) who were evaluated. A test of a targeted intervention was performed in 18 patients (44%). CONCLUSIONS Deep phenotyping and whole-exome sequencing in 41 probands with intellectual developmental disorder and unexplained metabolic abnormalities led to a diagnosis in 68%, the identification of 11 candidate genes newly implicated in neurometabolic disease, and a change in treatment beyond genetic counseling in 44%. (Funded by BC Children's Hospital Foundation and others.).

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Editorial: The Post-Exome Era

The Iranian Rehabilitation Journal (IRJ) invites research papers on the genetic basis of single gene and complex disorders. This vastly dynamic branch of science will complement the multidisciplinary wealth of expertise in the fields of social welfare and rehabilitation. The past few years have witnessed outstanding research projects on the genetic causes of numerous debilitating disorders, suc...

متن کامل

Identification of the rs797045105 in the SERAC1 gene by Whole-Exome Sequencing in a Patient Suspicious of MEGDEL Syndrome

Whole Exome Sequencing (WES) has been increasingly utilized in genetic determinants of various inherited diseases. We identified a new variation in SERAC1 as the cause of 3-Methylglutaconic Aciduria (MEG), Deafness (D), Encephalopathy (E), and Leigh-like (L), MEGDEL syndrome using WES. We found an insertion, rs797045105 (chr6, 158571484, C>CCATG), in the SERAC1 gene with homozygous genotype in ...

متن کامل

Whole Exome Sequencing Reveals a BSCL2 Mutation Causing Progressive Encephalopathy with Lipodystrophy (PELD) in an Iranian Pediatric Patient

Background: Progressive encephalopathy with or without lipodystrophy is a rare autosomal recessive childhood-onset seipin-associated neurodegenerative syndrome, leading to developmental regression of motor and cognitive skills. In this study, we introduce a patient with developmental regression and autism. The causative mutation was found by exome sequencing. Methods: The proband showed a gener...

متن کامل

NF1 Mutations Analysis Using Whole Exome Sequencing Technique in 11 Unrelated Iranian Families with Neurofibromatosis Type 1

Background Neurofibromatosis is an autosomal dominant disease. It affects one in 2,700 to 3,300 people. The main gene mutated in the disease is a tumor suppressor protein called neurofibromin. There are several categories, the most important of which is divided into two types of type I and type 2 neurofibromatosis. Here, we aimed to identify th...

متن کامل

I-39: Exome Sequencing Reveals New Genes Involved in Human Infertility

Background - MaterialsAndMethods N;Results N;Conclusion N;

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The New England journal of medicine

دوره 374 23  شماره 

صفحات  -

تاریخ انتشار 2016